Table 3. Clinical and laboratory characteristics of the study patients.
| Variable | Control group (N = 127), n (%) | Intervention group (N = 127), n (%) | P value | Overall P-value |
|---|---|---|---|---|
| Time to presentation from stroke onset | 0.015 | |||
| Within 24 hours | 38 (29.9) | 26 (20.5) | 0.085 | |
| 24–48 hours | 26 (20.5) | 22 (17.3) | 0.515 | |
| > 48 hours to 7 days | 63 (49.6) | 79 (62.2) | 0.043 | |
| Time of arrival | ||||
| Favorable | 67 (52.8) | 73 (57.5) | ||
| Unfavorable | 60 (47.2) | 54 (42.5) | 0.449 | |
| Stroke subtype | ||||
| Hemorrhagic | 39 (30.7) | 52 (40.9) | ||
| Ischemic | 88 (69.3) | 75 (59.1) | 0.090 | |
| Temperature | ||||
| Afebrile (temp < 37.5°C) | 118 (92.9) | 112 (88.2) | ||
| Febrile (temp ≥ 37.5°C) | 9 (7.1) | 15 (11.8) | 0.200 | |
| Admission blood pressure (BP) | ||||
| BP < 140/90mmHg | 30 (23.6) | 26 (20.5) | ||
| BP ≥ 140/90mmHg | 97 (76.4) | 101 (79.5) | 0.551 | |
| Level of consciousness at admission | ||||
| GCS ≥ 9 | 111 (87.4) | 106 (83.5) | ||
| GCS < 9 | 16 (12.6) | 21 (16.5) | 0.378 | |
| Stroke severity at admission | 0.002 | |||
| Mild (45–58) | 20 (15.7) | 8 (6.3) | 0.017 | |
| Moderate (30–44) | 25 (19.7) | 14 (11.0) | 0.054 | |
| Severe (15–29) | 43 (33.9) | 51 (40.2) | 0.299 | |
| Very severe (0–14) | 39 (30.7) | 54 (42.5) | 0.051 | |
| Disability at admission | 0.406 | |||
| Independent | 18 (14.2) | 10 (7.9) | 0.109 | |
| Partially dependent | 19 (14.9) | 26 (20.5) | 0.242 | |
| Totally dependent | 90 (70.9) | 91 (71.6) | 0.902 | |
| Fasting blood sugar | 0.013 | |||
| Normal | 65 (51.2) | 46 (36.2) | 0.016 | |
| IGT | 25 (20.5) | 29 (22.8) | 0.656 | |
| High | 36 (28.3) | 52 (40.9) | 0.035 | |
| Total cholesterol | 0.002 | |||
| Normal | 41 (32.3) | 56 (44.1) | 0.053 | |
| Borderline | 20 (15.8) | 35 (27.6) | 0.023 | |
| High | 66 (51.9) | 36 (28.3) | <0.001 | |
| LDL cholesterol | 0.001 | |||
| Normal | 70 (55.1) | 94 (74.0) | 0.002 | |
| Borderline | 16 (12.6) | 12 (9.5) | 0.415 | |
| High | 41 (32.3) | 21 (16.5) | 0.003 | |
| HDL cholesterol | 0.001 | |||
| Normal | 38 (29.9) | 68 (53.5) | <0.0001 | |
| Borderline | 59 (46.5) | 53 (41.7) | 0.441 | |
| High | 30 (23.6) | 6 (4.7) | <0.0001 | |
| Triglycerides | 0.756 | |||
| Normal | 101 (79.5) | 103 (81.1) | 0.749 | |
| Borderline | 15 (11.8) | 14 (11.0) | 0.841 | |
| High | 11 (8.7) | 10 (7.9) | 0.817 | |
| Rapid plasma reagin | ||||
| Nonreactive RPR | 118 (92.9) | 127 (100) | ||
| Reactive RPR | 9 (7.1) | 0 (0.00) | 0.002 | |
| HIV | ||||
| Negative | 121 (95.3) | 124 (97.6) | ||
| Positive | 6 (2.7) | 3 (2.4) | 0.322 | |
| WBC count | 0.053 | |||
| Low | 13 (10.2) | 6 (4.7) | 0.095 | |
| Normal | 97 (76.4) | 96 (75.6) | 0.881 | |
| High | 17 (13.4) | 25 (19.7) | 0.177 |
IGT Impaired glucose tolerance, LDL low density lipoprotein, HDL high density lipoprotein, RPR rapid plasma reagin, WBC white blood cell, GCS Glasgow coma score.